Search

From 2018 to 2022, IPATH initiated phage hunts for 265 patients, but 25% couldn't proceed due to lack of phages. IPATH has now partnered with Korean phage company MicrobiotiX; IPATH will screen and send sample isolates to MicrobiotiX, who w

Dr. Evelien Adriaenssens and Dr. Matthew Gilmour (Quadram Institute, Norwich, UK) have won BBSRC partnership awards to collaborate with Canadian researchers! Dr. Adriaenssens’ partnership is with Dr. Hany Anany's lab at Agriculture and Agri

Liechtenstein company Lysando AG and Korean company Amicogen Inc. have forged a strategic partnership. Lysando creates Artilysin®s, which are phage lysin-based antimicrobial proteins, and partnering with Amicogen will allow them to access t